Market research
HAEK.F HAEMATO AG
F EUR Not available
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 79M
- P/E ratio
- 8.14
- Analyst target
- Not available
- Dividend yield
- 8.0%
- Beta
- 1.29
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- DE000A289VV1
- Market cap
- 79M
- P/E ratio
- 8.14
- Analyst target
- Not available
- Dividend yield
- 8.0%
- Beta
- 1.29
About
About HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the HAEK.F discussion.
5 years, 5 months ago
HAEMATO AG is currently in a long term uptrend where the price is trading 10.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Based on the above factors, HAEMATO AG gets an overall score of 2/5.